Molly McGlaughlin has over 27 years’ experience in the Biotechnology industry in both developing Biologic manufacturing business units and licensing and partnering technology. She has a solid P&L performance and business strategy track record. Ms. McGlaughlin has held positions on the management team of Eirgenix, Natrix Separations, BioVectra, Selexys S.A., Cytovance Biologics, Avecia Biotechnology, Patheon, Mallinckrodt, and most recently as Chief Operating Office of Vigene Bioscience a Gene and Cell therapy manufacturing company. Molly holds a BS in Biology from Norwich University, Military College of Vermont, a Masters in Organizational Performance Improvement from University of Massachusetts, Boston, Masters in Strategic Studies from the U.S. Army War College, and is ABD in the School of Business and Technology at Capella University where her doctoral studies focus on M&A in the Biotechnology Industry. Molly is also a long-time member of the U.S. Army Reserves where she held the rank of Colonel and has Commanded at the Brigade level.